Your browser doesn't support javascript.
loading
Vonoprazan poses no additional risk of developing Clostridioides difficile infection compared to proton pump inhibitors.
Saruta, Yohei; Watanabe, Kenta; Tsuji, Tsuyotoshi; Takahashi, Yasutaka; Matsuzawa, Hisanori; Yoshida, Tatsuki; Takahashi, So; Shimodaira, Yosuke; Matsuhashi, Tamotsu; Iijima, Katsunori.
Affiliation
  • Saruta Y; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Watanabe K; Department of Gastroenterology, Akita City Hospital, Akita, Japan.
  • Tsuji T; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Takahashi Y; Department of Gastroenterology, Akita City Hospital, Akita, Japan.
  • Matsuzawa H; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Yoshida T; Department of Gastroenterology, Akita City Hospital, Akita, Japan.
  • Takahashi S; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Shimodaira Y; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Matsuhashi T; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
  • Iijima K; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
J Gastroenterol Hepatol ; 38(6): 940-947, 2023 Jun.
Article in En | MEDLINE | ID: mdl-36882162
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Clostridioides difficile / Clostridium Infections Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article